The Valley Desk

NCT02374333 · Interventional trial

Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy

Overall registry status Completed

Phase 1

Conditions Acute Lymphocytic Leukemia, Diffuse Large Cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov